Biodexa Pharmaceuticals Plc (BDRX)

Biodexa Pharmaceuticals Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	5.06	5.97	2.84	10.06	7.55	10.93
Cash & Short-Term Investments	5.06	5.97	2.84	10.06	7.55	10.93
Cash Growth	-3.29%	110.54%	-71.80%	33.28%	-30.95%	366.41%
Accounts Receivable	1.92	-	0.33	0.03	0.1	0.02
Other Receivables	0.55	0.7	1.15	1.06	1.38	2.64
Receivables	2.47	0.7	1.48	1.1	1.47	2.66
Prepaid Expenses	-	0.36	0.38	0.61	0.26	0.15
Total Current Assets	7.52	7.03	4.69	11.76	9.28	13.74
Property, Plant & Equipment	0.44	0.57	0.83	1.15	0.54	2.15
Goodwill	-	-	-	-	-	2.29
Other Intangible Assets	6.01	2.94	0.01	-	-	10.09
Other Long-Term Assets	-	-	-	-	-	2.63
Total Assets	13.97	10.54	5.53	12.91	9.82	30.9
Accounts Payable	1.69	0.31	0.34	0.49	0.34	0.73
Accrued Expenses	-	0.86	0.82	0.55	0.77	1.77
Current Portion of Long-Term Debt	-	-	-	-	0.11	0.18
Current Portion of Leases	0.17	0.17	0.16	0.15	0.09	0.23
Current Income Taxes Payable	-	0.06	0.08	0.06	0.03	0.09
Current Unearned Revenue	-	-	0.2	-	0.07	1.91
Other Current Liabilities	1.62	4.17	0.31	0.61	1.59	0.77
Total Current Liabilities	3.48	5.57	1.9	1.84	2.99	5.67
Long-Term Debt	-	-	-	-	-	4.76
Long-Term Leases	0.21	0.3	0.46	0.62	0.06	0.91
Other Long-Term Liabilities	1.55	-	-	-	0.05	-
Total Liabilities	5.24	5.86	2.36	2.46	3.1	11.34
Common Stock	3.63	1.19	0.11	0.1	0.06	0.02
Additional Paid-In Capital	91.24	86.73	83.67	83.43	74.36	65.88
Retained Earnings	-147.88	-144.77	-135.34	-127.8	-122.43	-99.84
Comprehensive Income & Other	61.74	61.52	54.72	54.72	54.72	53.5
Shareholders' Equity	8.73	4.68	3.16	10.45	6.72	19.56
Total Liabilities & Equity	13.97	10.54	5.53	12.91	9.82	30.9
Total Debt	0.38	0.46	0.62	0.77	0.26	6.08
Net Cash (Debt)	4.67	5.51	2.21	9.29	7.29	4.85
Net Cash Growth	-0.21%	148.96%	-76.19%	27.52%	50.35%	344.18%
Net Cash Per Share	24.51	174.35	-	-	-	-
Filing Date Shares Outstanding	0.36	0.18	-	-	-	-
Total Common Shares Outstanding	0.36	0.12	-	-	-	-
Working Capital	4.04	1.46	2.79	9.92	6.29	8.07
Book Value Per Share	24.07	39.32	-	-	-	-
Tangible Book Value	2.72	1.74	3.16	10.45	6.72	7.18
Tangible Book Value Per Share	7.50	14.60	-	-	-	-
Machinery	-	1.52	1.59	1.87	1.95	4.39
Leasehold Improvements	-	0.05	0.05	0.05	0	2.04

Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q